These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2570995)

  • 1. Retinoic acid therapy for promyelocytic leukaemia.
    Chomienne C; Ballerini P; Balitrand N; Amar M; Bernard JF; Boivin P; Daniel MT; Berger R; Castaigne S; Degos L
    Lancet; 1989 Sep; 2(8665):746-7. PubMed ID: 2570995
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid.
    Degos L; Chomienne C; Daniel MT; Berger R; Dombret H; Fenaux P; Castaigne S
    Lancet; 1990 Dec; 336(8728):1440-1. PubMed ID: 1978887
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term survival of acute promyelocytic leukaemia patients treated with arsenic and retinoic acid.
    Zhu HH; Wu DP; Jin J; Li JY; Ma J; Wang JX; Chen SJ; Huang XJ
    Br J Haematol; 2016 Sep; 174(5):820-2. PubMed ID: 27545413
    [No Abstract]   [Full Text] [Related]  

  • 4. All trans-retinoic acid in the treatment of promyelocytic leukaemia--a case report.
    Hoe TS; Cheong SK; Hussin NH; Chum KW
    Med J Malaysia; 1992 Sep; 47(3):225-7. PubMed ID: 1491649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system relapse in acute promyelocytic leukaemia treated with all-trans retinoic acid.
    Seldon M; Enno A
    Aust N Z J Med; 1998 Aug; 28(4):462. PubMed ID: 9777115
    [No Abstract]   [Full Text] [Related]  

  • 6. [Primary treatment of acute promyelocytic leukemia using all-trans-retinoic acid].
    Leeksma OC; van Oers MH; van der Schoot CE; Goudsmit R; von dem Borne AE
    Ned Tijdschr Geneeskd; 1993 Apr; 137(16):821-5. PubMed ID: 8487886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
    N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudotumour cerebri as a manageable side effect of prolonged all-trans retinoic acid therapy in an adult patient with acute promyelocytic leukaemia.
    Gallipoli P; Drummond MW
    Eur J Haematol; 2009 Mar; 82(3):242-3. PubMed ID: 19018859
    [No Abstract]   [Full Text] [Related]  

  • 9. All-trans retinoic acid in the treatment of acute promyelocytic leukaemia.
    White KL; Wiley JS; Frost T; McKendrick JJ; Hermann RP; Seldon M; Enno A; Bell R; Bunce I; Taylor K
    Aust N Z J Med; 1992 Oct; 22(5):449-54. PubMed ID: 1445034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restitution of normal marrow morphology and karyotype in acute refractory acute promyelocytic leukaemia with all-trans retinoic acid.
    Creagh MD; Clark DJ; Collin RC
    Br J Haematol; 1991 Aug; 78(4):572. PubMed ID: 1911349
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful remission induction by low-dose all-trans retinoic acid alone in a patient with acute promyelocytic leukemia and renal impairment.
    Matsumoto K; Tamaki H; Yamagami T; Sasaki N; Hara S; Soma T
    Leuk Res; 2008 Mar; 32(3):512-4. PubMed ID: 17588659
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo evidence of all-trans retinoic acid inducing maturation in acute promyelocytic leukaemia.
    Hamidah HN; Cheong SK; Ainoon O
    Acta Haematol; 1993; 89(1):50-1. PubMed ID: 8480488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful management of an octogenarian with acute promyelocytic leukemia using all-trans retinoic acid.
    Sham R
    Am J Hematol; 1995 Jul; 49(3):263-5. PubMed ID: 7604830
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide.
    Sasaki M; Sugimoto K; Isobe Y; Oshimi K
    Eur J Haematol; 2008 Aug; 81(2):160. PubMed ID: 18363868
    [No Abstract]   [Full Text] [Related]  

  • 15. [All-trans-retinoic acid in the treatment of acute promyelocytic leukemia].
    Degos L
    Presse Med; 1990 Oct; 19(32):1483-4. PubMed ID: 2146649
    [No Abstract]   [Full Text] [Related]  

  • 16. History of promyelocytic leukaemia.
    Bernard J
    Leukemia; 1994; 8 Suppl 2():S1-5. PubMed ID: 7815829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy].
    Lengfelder E; Simon M; Haase D; Hild F; Hehlmann R
    Dtsch Med Wochenschr; 1994 Aug; 119(34-35):1143-50. PubMed ID: 8076501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment of acute promyelocytic leukemia with retinoic acid].
    Iavorkovskiĭ LI; Udris OIu; Iavorkovskiĭ LL
    Ter Arkh; 1994; 66(2):87-9. PubMed ID: 8160157
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute promyelocytic leukemia: retinoic acid response and resistance.
    Early E; Dmitrovsky E
    J Investig Med; 1995 Aug; 43(4):337-44. PubMed ID: 7552583
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.
    Iland HJ; Collins M; Bradstock K; Supple SG; Catalano A; Hertzberg M; Browett P; Grigg A; Firkin F; Campbell LJ; Hugman A; Reynolds J; Di Iulio J; Tiley C; Taylor K; Filshie R; Seldon M; Taper J; Szer J; Moore J; Bashford J; Seymour JF;
    Lancet Haematol; 2015 Sep; 2(9):e357-66. PubMed ID: 26685769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.